Close Menu

NEW YORK – Natera on Tuesday filed a countersuit against CareDx, accusing the molecular diagnostics company of false advertising, "tortious interference with Natera's prospective economic advantage," unfair competition, and violations of the Delaware Uniform Deceptive Trade Practices Act.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.